AbbVie
ABBV
ABBV
3,335 hedge funds and large institutions have $216B invested in AbbVie in 2024 Q2 according to their latest regulatory filings, with 153 funds opening new positions, 1,453 increasing their positions, 1,308 reducing their positions, and 123 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3,335
Holders Change
-17
Holders Change %
-0.51%
% of All Funds
48.5%
Holding in Top 10
176
Holding in Top 10 Change
-46
Holding in Top 10 Change %
-20.72%
% of All Funds
2.56%
New
153
Increased
1,453
Reduced
1,308
Closed
123
Calls
$2.77B
Puts
$2.09B
Net Calls
+$686M
Net Calls Change
-$48.9M
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$1.01B |
| 2 |
Franklin Resources
San Mateo,
California
|
+$825M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
+$517M |
| 4 |
Goldman Sachs
New York
|
+$467M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$387M |
Top Sellers
| 1 |
Capital International Investors
Los Angeles,
California
|
-$1.63B |
| 2 |
BlackRock
New York
|
-$1.12B |
| 3 |
Bank of New York Mellon
New York
|
-$395M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$169M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$139M |
